4 completed, 2 recruiting, 1 unknown. 1 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Myotoxicity: new trials by email Literature Review of Myotoxicity trials Research Report on Myotoxicity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ATROPOS: Survival Analysis of ICI-associated Myocarditis Immune Checkpoint Inhibitor-associated Myocarditis | Recruiting | Groupe Hospitalier Pitie-Salpetriere | 1500 | 2026-05-20 | 2026-06-10 | |
| CPK Levels After LC and Association With Analgesic Modalities İnterfascial plane block, Standart analgesia plan - Myotoxicity | Completed | Samsun University | 80 | 2024-08-05 | 2025-06-24 | |
| The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA) Propofol, Rocuronium - Kidney Failure, Acute, Myopathy; Drugs | Not applicable | Recruiting | 4th Military Clinical Hospital with Polyclinic, Poland | 32 | 2024-08-01 | 2024-11-27 |
| Effects of Postoperative Analgesic Modalities on Plasma Creatine Phosphokinase(CPK) Levels After Knee Artroplasty suprainguinal fascia iliaca block - Myotoxicity | Completed | Samsun University | 82 | 2022-12-16 | 2023-02-22 | |
| Defining Normal Postoperative Magnetic Resonance Imaging After Total Knee Arthroplasty Local Anesthetic Complication, Local Anesthetic Drug Adverse Reaction | Completed | Benaroya Research Institute | 36 | 2018-12-04 | 2021-05-25 | |
| Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia Pregabalin, Placebo - Taxane, Drug-related Side Effects and Adverse Reactions | Phase 2 | Unknown | Assaf-Harofeh Medical Center | 38 | 2013-12-01 | 2013-12-31 |
| Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity atorvastatin - Muscular Diseases | Phase 4 | Completed | Oslo University Hospital | 53 | 2005-10-01 | 2012-05-10 |
Acute Kidney Injury (1) · Agnosia (1) · Arrhythmias, Cardiac (1) · Breast Neoplasms (1) · Butyrylcholinesterase deficiency (1) · Chronic Pain (1) · Drug-Related Side Effects and Adverse Reactions (1) · Muscle Hypotonia (1) · Muscular Diseases (1) · Myocarditis (1) · Myositis (1) · Pain (1)
Chemically-Induced Disorders (7) · Musculoskeletal Diseases (7) · Nervous System Diseases (7) · Neuromuscular Diseases (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Radiation Injuries (7) · Wounds and Injuries (7) · Drug-Related Side Effects and Adverse Reactions (6) · Muscular Diseases (6) · Cardiovascular Diseases (2) · Heart Diseases (2) · Neurologic Manifestations (2) · Signs and Symptoms (2) · Breast Diseases (1)
Anesthesia, General (1) · Atorvastatin (1) · Pregabalin (1) · Propofol (1) · Rocuronium (1)
Samsun University (2) · 4th Military Clinical Hospital with Polyclinic, Poland (1) · Assaf-Harofeh Medical Center (1) · Benaroya Research Institute (1) · Groupe Hospitalier Pitie-Salpetriere (1) · Oslo University Hospital (1)
Turkey (Türkiye) (2) · France (1) · Israel (1) · Norway (1) · Poland (1) · United States (1)
Serkan Tulgar (2) · Jonathan Grunfeld, M.D. (1) · Joseph M Neal, MD (1) · Marek Szamborski, MD (1)